Docetaxel and Paronychia - a phase IV clinical study of FDA data
Summary:
We study 70,009 people who have side effects when taking Docetaxel. Paronychia is found, especially among people who are female, 60+ old, have been taking the drug for 1 - 6 months, also take Herceptin and have Breast cancer.
The phase IV clinical study analyzes which people take Docetaxel and have Paronychia. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
70,009 people reported to have side effects when taking Docetaxel.
Among them, 146 people (0.21%) have Paronychia.
What is Docetaxel?
Docetaxel has active ingredients of docetaxel. Currently, eHealthMe is studying from 75,890 Docetaxel users.
What is Paronychia?
Paronychia (infection in the tissues adjacent to a nail on a finger or toe) is found to be associated with 1,275 drugs and 693 conditions by eHealthMe. Currently, we are studying 5,570 people who have Paronychia.
Number of Docetaxel and Paronychia reports submitted per year:

Time on Docetaxel when people have Paronychia *:
Gender of people who have Paronychia when taking Docetaxel*:
Age of people who have Paronychia when taking Docetaxel *:
Common drugs people take besides Docetaxel *:
Common side effects people have besides Paronychia *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Docetaxel and have Paronychia?
Check whether Paronychia is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Byun JS, Kang SH, Lee MJ, Kim SY, Choi HG, Lee HR, "A Case of Scleroderma-like Cutaneous Lesions Induced by Docetaxel in a Patient with Breast Cancer", Journal of Rheumatic Diseases, 2013 Oct .
Related studies
Docetaxel side effects by duration, gender and age:
- Docetaxel side effects (75,890 reports)
Paronychia treatments and more:
- Paronychia (5,570 reports)
Common drugs associated with Paronychia:
- Fluorouracil: 441 reports
- Oxaliplatin: 438 reports
- Gilotrif: 390 reports
- Vectibix: 260 reports
- Methotrexate: 182 reports
- Erbitux: 181 reports
- Prednisone: 181 reports
- Xeloda: 173 reports
- Capecitabine: 153 reports
- Docetaxel: 146 reports
All the drugs that are associated with Paronychia:
- Paronychia (1,275 drugs)
Common conditions associated with Paronychia:
- Colon cancer: 459 reports
- Lung cancer - non-small cell: 401 reports
- Rheumatoid arthritis: 246 reports
- High blood pressure: 226 reports
- Breast cancer: 215 reports
- Preventive health care: 208 reports
All the conditions that are associated with Paronychia:
- Paronychia (693 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on docetaxel (the active ingredients of Docetaxel) and Docetaxel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Prosom and Betapace drug interaction - 4 seconds ago
- Arginine and Soliris drug interaction - 5 seconds ago
- Temazepam and Adjustment Disorder With Depressed Mood - 8 seconds ago
- Promacta and Glycolax drug interaction - 20 seconds ago
- Lomotil and Immune System Disorder - 22 seconds ago
- Belbuca and Diarrhea - 23 seconds ago
- Belbuca and Stools - Watery - 23 seconds ago
- Pulmozyme and Ergocalciferol drug interaction - 24 seconds ago
- Zantac 150 and Zoloft drug interaction - 24 seconds ago
- Pitavastatin and Sinusitis - 25 seconds ago